Wolverine Trading, LLC Sorrento Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $386,711 - $737,568	256,100 New	256,100 $405,000
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.33 $174,592 - $328,064	-140,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $281,600 - $689,920	140,800 New	140,800 $334,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $914,655 - $1.42 Million	-196,700 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.41 - $10.99 $342,342 - $507,738	-46,200 Reduced 19.02%	196,700 $1.46 Million
Q2 2021 Aug 06, 2021	BUY	$6.35 - $10.0 $372,110 - $586,000	58,600 Added 31.8%	242,900 $2.36 Million
Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $667,850 - $1.57 Million	-95,000 Reduced 34.01%	184,300 $1.47 Million
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $280,512 - $581,965	48,700 Added 21.12%	279,300 $2.02 Million
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $1.42 Million - $4.34 Million	230,600 New	230,600 $2.68 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.